Atorvastatin 40mg Tablet

DRUG3 trials

Sponsors

Cambridge University Hospitals NHS Foundation Trust, French Cardiology Society, National University Hospital, Singapore

Conditions

AtherosclerosisCardiovascular DiseasesMetabolite

Phase 3

Pharmaco-metabolomic Effects of Statins: METASTATINE

CompletedNCT03837925

French Cardiology SocietyCardiovascular Diseases

Start: 2019-06-13End: 2022-12-21Updated: 2023-01-18

Phase 4

Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

RecruitingNCT06690164

National University Hospital, SingaporeMetabolite

Start: 2025-06-12End: 2026-06-30Target: 78Updated: 2025-07-02

Unknown Phase

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

Cambridge University Hospitals NHS Foundation TrustAtherosclerosis, Cardiovascular Diseases

Start: 2017-11-30End: 2023-11-30Updated: 2021-07-23

Related Papers

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study

BMJ Open2021-04-015 citations